Atrogin-1 and Muscle Protein Balance

Atrogin-1 和肌肉蛋白质平衡

• 批准号: 6607952
• 负责人: STEWART H LECKER
• 金额: $ 36.04万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6607952
• 关键词: atrophy; enzyme activity; functional /structural genomics; gene expression; gene targeting; genetically modified animals; laboratory mouse; ligase; protein degradation; protein structure function; regulatory gene; tissue /cell culture; ubiquitin; yeast two hybrid system

DESCRIPTION (provided by applicant): Muscle wasting and negative nitrogen balance are debilitating features of many disease states including diabetes, chronic renal failure and cancer. We have recently identified a new gene, atrogin-1, which is expressed specifically in skeletal muscle and is strongly induced when muscle atrophies in various animal models of these diseases. The atrogin-1 protein contains an F-box, suggesting that it may act as a ubiquitin-protein ligase that catalyzes the ubiquitination and degradation of key proteins, leading to muscle wasting. This proposal is an outgrowth of studies which were initiated in Dr. Alfred Goldberg's laboratory, where Dr. Lecker was a postdoctoral fellow, and will now be continued mainly in the independent laboratory of Dr. Lecker. The functions and importance of this novel protein will be clarified by utilizing a combination of genetic and biochemical approaches. Muscle cells in culture will be engineered to inducibly express atrogin-1, so that its effects on muscle growth, differentiation and atrophy can be studied. The mouse atrogin-1 gene will be disrupted to generate a knockout strain where we can test whether mice lacking atrogin-1 can develop muscle atrophy. In an effort to understand how atrogin-1 might promote muscle protein breakdown, we will attempt to identify its targets and cofactors by the yeast two-hybrid approach and biochemical isolation of atrogin-1-associated proteins. Finally, we will develop in vitro assays to measure the ability of atrogin-1 to conjugate ubiquitin to proteins. Elucidating the functions of atrogin-1 will not only help characterize the mechanisms and physiological regulation of muscle protein breakdown but may also allow the development of pharmacological inhibitors that could combat muscle wasting conditions and its associated morbidity (e.g. the uremia in renal failure).

描述（由申请人提供）：肌肉萎缩和负氮平衡是许多疾病状态的衰弱特征，包括糖尿病，慢性肾衰竭和癌症。我们最近发现了一个新的基因，atrogin-1，它在骨骼肌中特异性表达，在这些疾病的各种动物模型中，当肌肉萎缩时被强烈诱导。atrogin1蛋白含有一个F-box，表明它可能作为泛素蛋白连接酶，催化关键蛋白的泛素化和降解，导致肌肉萎缩。这一提议是在阿尔弗雷德·戈德堡博士的实验室发起的研究的结果，莱克博士在那里做博士后，现在将主要在莱克博士的独立实验室继续进行。这种新蛋白的功能和重要性将通过遗传学和生物化学方法的结合来阐明。我们将在培养的肌肉细胞中诱导表达atroggin -1，从而研究其对肌肉生长、分化和萎缩的影响。老鼠的抗萎缩素-1基因将被破坏，产生一个基因敲除菌株，我们可以测试缺乏抗萎缩素-1的老鼠是否会出现肌肉萎缩。为了了解atrogin-1如何促进肌肉蛋白分解，我们将尝试通过酵母双杂交方法和atrogin-1相关蛋白的生化分离来确定其靶点和辅助因子。最后，我们将开发体外实验来测量阿特罗酮-1将泛素结合到蛋白质上的能力。阐明atrogin-1的功能不仅有助于表征肌肉蛋白分解的机制和生理调节，还可能有助于开发药物抑制剂，以对抗肌肉萎缩及其相关的发病率（例如肾衰竭中的尿毒症）。